BioNexus Gene Lab - 5 Year Stock Price History | BGLC
Historical daily share price chart and data for BioNexus Gene Lab since 2020 adjusted for splits and dividends. The latest closing stock price for BioNexus Gene Lab as of May 23, 2025 is 2.94.
- The all-time high BioNexus Gene Lab stock closing price was 285.60 on March 03, 2021.
- The BioNexus Gene Lab 52-week high stock price is 8.40, which is 185.7% above the current share price.
- The BioNexus Gene Lab 52-week low stock price is 2.01, which is 31.6% below the current share price.
- The average BioNexus Gene Lab stock price for the last 52 weeks is 3.72.
| BioNexus Gene Lab Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 3.2197 | 3.9900 | 4.6100 | 2.1700 | 2.9400 | 5.00% |
| 2024 | 4.9680 | 5.2200 | 15.7000 | 2.2900 | 2.8000 | -47.17% |
| 2023 | 42.5774 | 120.0000 | 144.0000 | 3.3000 | 5.3000 | -95.35% |
| 2022 | 161.2843 | 240.0000 | 267.6000 | 86.4000 | 114.0000 | -55.40% |
| 2021 | 207.8730 | 0.0023 | 285.6000 | 0.0017 | 255.6000 | 11112943.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.174B | 25.17 |
| Elevance Health (ELV) | United States | $86.874B | 11.21 |
| CVS Health (CVS) | United States | $76.179B | 9.47 |
| Cencora (COR) | United States | $56.230B | 19.56 |
| DiDi Global (DIDIY) | China | $23.297B | 35.36 |
| Natera (NTRA) | United States | $20.821B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.571B | 13.31 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.522B | 0.00 |
| CochLear (CHEOY) | Australia | $11.391B | 0.00 |
| Revvity (RVTY) | United States | $10.665B | 18.35 |
| ICON (ICLR) | Ireland | $10.255B | 9.53 |
| Viatris (VTRS) | United States | $9.976B | 3.43 |
| Doximity (DOCS) | United States | $9.570B | 44.57 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.657B | 42.59 |
| Medpace Holdings (MEDP) | United States | $8.422B | 22.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.660B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.994B | 36.97 |
| Bausch + Lomb (BLCO) | Canada | $3.976B | 23.44 |
| Sotera Health (SHC) | United States | $3.480B | 19.77 |
| Surgery Partners (SGRY) | United States | $2.896B | 37.67 |
| Alignment Healthcare (ALHC) | United States | $2.867B | 0.00 |
| Concentras Parent (CON) | United States | $2.744B | 15.86 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.117B | 9.02 |
| GeneDx Holdings (WGS) | United States | $1.921B | 73.99 |
| Premier (PINC) | United States | $1.910B | 14.50 |
| Progyny (PGNY) | United States | $1.791B | 39.42 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.200B | 9.13 |
| Establishment Labs Holdings (ESTA) | $1.066B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.953B | 14.88 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| Nutex Health (NUTX) | United States | $0.901B | 13.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.614B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| LifeMD (LFMD) | United States | $0.523B | 0.00 |
| Enhabit (EHAB) | United States | $0.520B | 42.75 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 11.37 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| SBC Medicals (SBC) | United States | $0.398B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.388B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.214B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.098B | 0.00 |
| So-Young (SY) | China | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |